Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Claudia Maria Trombetta, Serena Marchi & Emanuele Montomoli. (2022) The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing. Expert Review of Vaccines 21:9, pages 1233-1242.
Read now
Read now
Claudia Maria Trombetta, Serena Marchi, Ilaria Manini, Giacomo Lazzeri & Emanuele Montomoli. (2019) Challenges in the development of egg-independent vaccines for influenza. Expert Review of Vaccines 18:7, pages 737-750.
Read now
Read now
Chiara Mameli, Enza D’auria, Paola Erba, Pilar Nannini & Gian Vincenzo Zuccotti. (2018) Influenza vaccine response: future perspectives. Expert Opinion on Biological Therapy 18:1, pages 1-5.
Read now
Read now
Articles from other publishers (20)
Ali Garjani, Atoosa Malemir Chegini, Mohammadreza Salehi, Alireza Tabibzadeh, Parastoo Yousefi, Mohammad Hossein Razizadeh, Moein Esghaei, Maryam Esghaei & Mohammad Hossein Rohban. (2023) Forecasting influenza hemagglutinin mutations through the lens of anomaly detection. Scientific Reports 13:1.
Crossref
Crossref
Manish M. Patel, Lisa A. Grohskopf, Suryaprakash Sambhara, Jessica A. Belser, Jacqueline M. Katz & Alicia M. Fry. 2023. Plotkin's Vaccines. Plotkin's Vaccines
514
551.e31
.
Keven Lothert & Michael W. Wolff. 2023. Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs). Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs)
145
169
.
Tessy A. H. Hick, Corinne Geertsema, Maurice G. L. Henquet, Dirk E. Martens, Stefan W. Metz & Gorben P. Pijlman. (2022) Secreted Trimeric Chikungunya Virus Spikes from Insect Cells: Production, Purification, and Glycosylation Status. Processes 10:1, pages 162.
Crossref
Crossref
Thomas Bissinger, Yixiao Wu, Pavel Marichal‐Gallardo, Dietmar Riedel, Xuping Liu, Yvonne Genzel, Wen‐Song Tan & Udo Reichl. (2021) Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering 118:10, pages 3996-4013.
Crossref
Crossref
Kobporn Boonnak, Chayasin Mansanguan, Dennis Schuerch, Usa Boonyuen, Hatairat Lerdsamran, Kultida Jiamsomboon, Fanny Sae Wang, Arun Huntrup, Jarunee Prasertsopon, Nathamon Kosoltanapiwat & Pilaipan Puthavathana. (2021) Molecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018–2019. Viruses 13:6, pages 977.
Crossref
Crossref
Kristen M. Tummillo & Karsten R.O. Hazlett. (2021) Co-Opting Host Receptors for Targeted Delivery of Bioconjugates—From Drugs to Bugs. Molecules 26:5, pages 1479.
Crossref
Crossref
Zachary R. Sia, Matthew S. Miller & Jonathan F. Lovell. (2020) Engineered Nanoparticle Applications for Recombinant Influenza Vaccines. Molecular Pharmaceutics 18:2, pages 576-592.
Crossref
Crossref
Elena Crouch, Jonathan Gonzalez, Erin Jacobs, Kurt Schaecher, Margaret Kehl, Martin Ottolini & Allison Malloy. (2021) Local Respiratory Viral Surveillance Can Focus Public Health Interventions to Decrease Influenza Disease Burden. Military Medicine 186:Supplement_1, pages 76-81.
Crossref
Crossref
Shailendra K. Saxena, Vimal K. Maurya, Swatantra Kumar & Madan L. B. Bhatt. 2020. Animal-Origin Viral Zoonoses. Animal-Origin Viral Zoonoses
135
144
.
Tanhai G Borkar & Vidul Goenka. (2019) Techniques Employed in Production of Traditional Vaccines Commonly Used by Military Forces: A Review. Journal of Archives in Military Medicine 7:1-2.
Crossref
Crossref
Daniel Vázquez-Ramírez, Ingo Jordan, Volker Sandig, Yvonne Genzel & Udo Reichl. (2019) High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system. Applied Microbiology and Biotechnology 103:7, pages 3025-3035.
Crossref
Crossref
Andrés Pizzorno, Blandine Padey, Olivier Terrier & Manuel Rosa-Calatrava. (2019) Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy. Frontiers in Immunology 10.
Crossref
Crossref
Patricia A. Jorquera, Vasiliy P. Mishin, Anton Chesnokov, Ha T. Nguyen, Brian Mann, Rebecca Garten, John Barnes, Erin Hodges, Juan De La Cruz, Xiyan Xu, Jackie Katz, David E. Wentworth & Larisa V. Gubareva. (2019) Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018. Scientific Reports 9:1.
Crossref
Crossref
Nicole Darricarrère, Svetlana Pougatcheva, Xiaochu Duan, Rebecca S. Rudicell, Te-Hui Chou, Joshua DiNapoli, Ted M. Ross, Tim Alefantis, Thorsten U. Vogel, Harry Kleanthous, Chih-Jen Wei & Gary J. Nabel. (2018) Development of a Pan-H1 Influenza Vaccine. Journal of Virology 92:22.
Crossref
Crossref
Joseph S. Bresee, Alicia M. Fry, Suryaprakash Sambhara & Nancy J. Cox. 2018. Plotkin's Vaccines. Plotkin's Vaccines
456
488.e21
.
Hari Pujar & Mats Lundgren. 2018. Biopharmaceutical Processing. Biopharmaceutical Processing
877
898
.
Barry C. Buckland. 2017. Engineering Health: How Biotechnology Changed Medicine. Engineering Health: How Biotechnology Changed Medicine
54
71
.
Patricia E Fast & Josephine H Cox. (2015) An influenza vaccine pill—can we swallow it?. The Lancet Infectious Diseases 15:9, pages 992-993.
Crossref
Crossref
Meagan Prescott, Hong Moulton & Manoj Pastey. (2022) Inhibition of Interferon Alpha by a Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer Increases Influenza Virus Replication in Chicken Embryo Fibroblast (DF-1) Cells; An Alternative Strategy to Increasing Vaccine Production in Cell Culture. SSRN Electronic Journal.
Crossref
Crossref